Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level - PubMed (original) (raw)

Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level

U M Wegenka et al. Mol Cell Biol. 1993 Jan.

Abstract

Interleukin-6 (IL-6) is known to be a major mediator of the acute-phase response in liver. We show here that IL-6 triggers the rapid activation of a nuclear factor, termed acute-phase response factor (APRF), both in rat liver in vivo and in human hepatoma (HepG2) cells in vitro. APRF bound to IL-6 response elements in the 5'-flanking regions of various acute-phase protein genes (e.g., the alpha 2-macroglobulin, fibrinogen, and alpha 1-acid glycoprotein genes). These elements contain a characteristic hexanucleotide motif, CTGGGA, known to be required for the IL-6 responsiveness of these genes. Analysis of the binding specificity of APRF revealed that it is different from NF-IL6 and NF-kappa B, transcription factors known to be regulated by cytokines and involved in the transcriptional regulation of acute-phase protein genes. In HepG2 cells, activation of APRF was observed within minutes after stimulation with IL-6 or leukemia-inhibitory factor and did not require ongoing protein synthesis. Therefore, a preexisting inactive form of APRF is activated by a posttranslational mechanism. We present evidence that this activation occurs in the cytoplasm and that a phosphorylation is involved. These results lead to the conclusions that APRF is an immediate target of the IL-6 signalling cascade and is likely to play a central role in the transcriptional regulation of many IL-6-induced genes.

PubMed Disclaimer

Cited by

Portal Hypertension in Alcohol-Associated Hepatitis.
McConnell MJ, Iwakiri Y. McConnell MJ, et al. Curr Hepatol Rep. 2023;22(2):67-73. doi: 10.1007/s11901-023-00601-y. Epub 2023 Apr 5. Curr Hepatol Rep. 2023. PMID: 37214274 Free PMC article. Review.
MiR-125b-5p/STAT3 Axis Regulates Drug Resistance in Osteosarcoma Cells by Acting on ABC Transporters.
Yang Y, Chen Y, Liu J, Zhang B, Yang L, Xue J, Zhang Z, Qin L, Bian R. Yang Y, et al. Stem Cells Int. 2023 Apr 29;2023:9997676. doi: 10.1155/2023/9997676. eCollection 2023. Stem Cells Int. 2023. PMID: 37159751 Free PMC article. Retracted.
Pan-cancer analysis reveals signal transducer and activator of transcription (STAT) gene family as biomarkers for prognostic prediction and therapeutic guidance.
Cheng M, Liu Y, Guo Y, Li M, Xian S, Qin H, Yang Y, Qian W, Tang J, Lu Y, Yao Y, Zhang M, Jin M, Xu L, Huang R, Xu D. Cheng M, et al. Front Genet. 2023 Mar 9;14:1120500. doi: 10.3389/fgene.2023.1120500. eCollection 2023. Front Genet. 2023. PMID: 36968603 Free PMC article.
Triptolide Inhibits Th17 Response by Upregulating microRNA-204-5p and Suppressing STAT3 Phosphorylation in Psoriasis.
He Q, Wu X, Shi Q. He Q, et al. Genet Res (Camb). 2022 Nov 17;2022:7468396. doi: 10.1155/2022/7468396. eCollection 2022. Genet Res (Camb). 2022. PMID: 36474621 Free PMC article.
DRUGGING "UNDRUGGABLE" DISEASE-CAUSING PROTEINS: FOCUS ON SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) 3.
Tweardy DJ. Tweardy DJ. Trans Am Clin Climatol Assoc. 2022;132:61-76. Trans Am Clin Climatol Assoc. 2022. PMID: 36196170 Free PMC article.

References

1. Proc Natl Acad Sci U S A. 1984 Apr;81(8):2313-6 - PubMed
1. Mol Cell Biol. 1987 Jan;7(1):305-13 - PubMed
1. Biochemistry. 1985 Apr 9;24(8):2077-86 - PubMed
1. Proc Natl Acad Sci U S A. 1985 Oct;82(20):6741-4 - PubMed
1. Cell. 1986 Dec 5;47(5):767-76 - PubMed

Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level - PubMed (original) (raw)